medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-12-21-23medsovet-1428Research ArticleБеременность и родыPregnancy and childbirthЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ БАКТЕРИАЛЬНОГО ВАГИНОЗА У БЕРЕМЕННЫХ АНТИСЕПТИКОМ ОКТЕНИДИНА ДИГИДРОХЛОРИДEFFECTIVENESS OF BACTERIAL VAGINOSIS THERAPY IN PREGNANT WOMEN BY OCTENIDINE DIHYDROCHLORIDE ANTISEPTICВасильченкоО. Н.VasilchenkoO. N.

Кандидат медицинских наук

PhD  in medicine

БаевО. Р.BaevO. R.

Доктор медицинских наук, профессор

Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова, МоскваРоссияKulakov Scientific Center of Obstetrics, Gynecology and Perinatology, MoscowRussian Federation2016301220160122123Copyright © Васильченко О.Н., Баев О.Р., 20162016Васильченко О.Н., Баев О.Р.Vasilchenko O.N., Baev O.R.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1428

Одно из первых мест в структуре заболеваний женских половых органов в настоящее время занимает бактериальный вагиноз, который, по  данным литературы,  диагностируется у  30–57,6%   женщин репродуктивного возраста [1,  2]. Бактериальный вагиноз – это инфекционный  невоспалительный синдром, характеризующийся  резким снижением или отсутствием лактофлоры и ее заменой на полимикробные ассоциации анаэробов и Gardnerellavaginalis, концентрация которых достигает 109–1011 КОЕ/мл вагинального отделяемого [3–5].

One of the first places in the structure of diseases of the female sexual organs is taken by bacterial vaginosis, which, by the literature data, is diagnosed in 30-57%  of women of the reproductive age [1, 2]. Bacterial vaginosis is an infectious noninflammatory syndrome characterized by a sharp reduction or lack of lactoflora and its replacement by polymicrobial associations of anaerobes and Gardnerella vaginalis, concentration of which achieves 109–1011 CFU/ml of vaginal discharge [3–5].

бактериальный вагинозбеременностьантисептикоктенидина дигидрохлоридbacterial vaginosispregnancyantisepticoctenidine dihydrochlorideReferencesКира Е.Ф. Бактериальный вагиноз. М.: МИА, 2012. 472 с. / Kira E.F. Bacterial vaginosis. M.: MIA, 2012, 472 p.Кира Е.Ф. Бактериальный вагиноз. М.: МИА, 2012. 472 с. / Kira E.F. Bacterial vaginosis. M.: MIA, 2012, 472 p.Pereira L, Chipato T, Mashu A et. al. Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine. Int. J. Gynaecol. Obstet., 2011 Mar, 112(3): 234-8. doi: 10.1016/j.ijgo.2010.09.009.Pereira L, Chipato T, Mashu A et. al. Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine. Int. J. Gynaecol. Obstet., 2011 Mar, 112(3): 234-8. doi: 10.1016/j.ijgo.2010.09.009.Sinha A, Sazawal S, Pradhan A et. al. Chlorhexidine skin or cord care for prevention of mortality and infections in neonates. Cochrane Database Syst Rev, 2015 Mar 5, 3: CD007835. doi: 10.1002/14651858.CD007835.pub2.Sinha A, Sazawal S, Pradhan A et. al. Chlorhexidine skin or cord care for prevention of mortality and infections in neonates. Cochrane Database Syst Rev, 2015 Mar 5, 3: CD007835. doi: 10.1002/14651858.CD007835.pub2.Novakov Mikic A, Budakov D. Comparison of local metronidazole and a local antiseptic in the treatment of bacterial vaginosis. Arch. Gynecol. Obstet., 2010 Jul, 282(1): 43-7. doi: 10.1007/s00404-009-1241-7.Novakov Mikic A, Budakov D. Comparison of local metronidazole and a local antiseptic in the treatment of bacterial vaginosis. Arch. Gynecol. Obstet., 2010 Jul, 282(1): 43-7. doi: 10.1007/s00404-009-1241-7.Wiegand C, Abel M, Ruth P et .al. pH influence on antibacterial efficacy of common antiseptic substances. Skin Pharmacol. Physiol., 2015, 28(3): 147-58. doi: 10.1159/000367632.Wiegand C, Abel M, Ruth P et .al. pH influence on antibacterial efficacy of common antiseptic substances. Skin Pharmacol. Physiol., 2015, 28(3): 147-58. doi: 10.1159/000367632.Тютюнник В.Л. Патогенез, диагностика и методы лечения бактериального вагиноза. Фарматека, 2005, 2(98): 20-24. / Tyutyunnik V.L. Pathogenesis, diagnostics and methods of therapy of bacterial vaginosis. Farmateka, 2005, 2 (98): 20-24.Тютюнник В.Л. Патогенез, диагностика и методы лечения бактериального вагиноза. Фарматека, 2005, 2(98): 20-24. / Tyutyunnik V.L. Pathogenesis, diagnostics and methods of therapy of bacterial vaginosis. Farmateka, 2005, 2 (98): 20-24.Briese V, Neumann G, Waldschläger J еt al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.Briese V, Neumann G, Waldschläger J еt al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst. Rev, 2014 Dec 21, 12: CD007892. doi: 10.1002/14651858.CD007892.pub5.Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst. Rev, 2014 Dec 21, 12: CD007892. doi: 10.1002/14651858.CD007892.pub5.Hadiati DR, Hakimi M, Nurdiati DS et. al. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev, 2014 Sep 17, 9: CD007462. doi: 10.1002/14651858.CD007462.pub3.Hadiati DR, Hakimi M, Nurdiati DS et. al. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev, 2014 Sep 17, 9: CD007462. doi: 10.1002/14651858.CD007462.pub3.Briese V, Neumann G, Waldschläger J et. al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.Briese V, Neumann G, Waldschläger J et. al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.Welk A, Zahedani M, Beyer C et al. Antibacterial and antiplaque efficacy of a commercially available octenidine-containing mouthrinse. Clin. Oral Investig., 2015 Nov 10. [Epub ahead of print].Welk A, Zahedani M, Beyer C et al. Antibacterial and antiplaque efficacy of a commercially available octenidine-containing mouthrinse. Clin. Oral Investig., 2015 Nov 10. [Epub ahead of print].Xu Z, Lai Y, Wu D et al. Antibacterial Effects and Biocompatibility of Titania Nanotubes with Octenidine Dihydrochloride/Poly(lactic-coglycolic acid). Biomed. Res. Int., 2015, 2015: 836939. doi: 10.1155/2015/836939.Xu Z, Lai Y, Wu D et al. Antibacterial Effects and Biocompatibility of Titania Nanotubes with Octenidine Dihydrochloride/Poly(lactic-coglycolic acid). Biomed. Res. Int., 2015, 2015: 836939. doi: 10.1155/2015/836939.Müller G, Langer J, Siebert J, Kramer A. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis. Skin Pharmacol. Physiol., 2014, 27(1): 1-8. doi: 10.1159/000350172.Müller G, Langer J, Siebert J, Kramer A. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis. Skin Pharmacol. Physiol., 2014, 27(1): 1-8. doi: 10.1159/000350172.Swidsinski A, Loening-Baucke V, Swidsinski S et. al. Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report. Arch. Gynecol. Obstet., 2015 Mar, 291(3): 605-9. doi: 10.1007/s00404-014-3484-1.Swidsinski A, Loening-Baucke V, Swidsinski S et. al. Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report. Arch. Gynecol. Obstet., 2015 Mar, 291(3): 605-9. doi: 10.1007/s00404-014-3484-1.

The authors declare that there are no conflicts of interest present.